Clinical Trials Directory

Trials / Completed

CompletedNCT01686009

Intra-nasal Ketamine for Analgesia in the Emergency Department

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Lions Gate Hospital · Academic / Other
Sex
All
Age
6 Years
Healthy volunteers
Not accepted

Summary

The provision of analgesia to patients in pain is a fundamental necessity of emergency department practice and is usually accomplished using IV opioids. However, significant barriers exist to the provision of timely analgesia by the IV route. The use of the IN route for medication delivery provides an efficient and relatively painless mode of analgesia delivery. As well, ketamine is well-known to be an effective analgesic and to preserve cardiorespiratory function thus removing the necessity of physiologic monitoring that is obligatory when using opioids. The use of ketamine by the IN route provides a rapid, easy-administered and well-tolerated method for providing analgesia in the ED setting.

Conditions

Interventions

TypeNameDescription
DRUGIntra-nasal ketamine

Timeline

Start date
2012-10-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2012-09-17
Last updated
2013-02-05

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01686009. Inclusion in this directory is not an endorsement.